Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Kymera Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues46.872.834.02.917.7
            Revenue growth-35.7%114.0%1060.0%-83.4% 
Cost of goods sold0.00.00.00.035.4
Gross profit46.872.834.02.9-17.7
            Gross margin100.0%100.0%100.0%100.0%-100.0%
Selling, general and administrative208.1173.480.345.1 
General and administrative    3.8
EBIT-161.4-100.7-46.4-42.3-21.5
            EBIT margin-344.7%-138.3%-136.4%-1440.0%-121.3%
Pre-tax income-154.8-100.2-45.6-41.2-21.5
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%
Net income-154.8-100.2-45.6-41.2-21.5
            Net margin-330.6%-137.6%-134.0%-1405.8%-121.4%
 
Diluted EPS($2.87)($2.09)($2.63)($24.28)($18.26)
Shares outstanding (diluted)53.948.017.31.71.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy